In this review:
Genome-wide analysis of HCV-1 patients from IDEAL
Waitlist mortality in HBV liver transplant candidates
Tenofovir in spontaneous HBV reactivation
Taribavirin vs. ribavirin in HCV-1 INFORM1:R7128+R7227
A highly immunogenic T-cell vaccine for HCV
Adding NAC
Please login below to download this issue (PDF)